Skip Navigation Links
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
National Center For Chronic Disease Prevention and Health Promotion
Tobacco Information and Prevention Source (TIPS)
TIPS Home | What's New | Mission | Fact Sheets | Site Map | Contact Us
Contents
• About Us
• Publications Catalog
• Surgeon General's Reports
• Research, Data, and Reports
• How To Quit
• Educational Materials
• New Citations
• Tobacco Control Program Guidelines & Data
• Celebrities Against Smoking
• Sports Initiatives
• Campaigns & Events
• Smoking and Health Database
• Related Links

 


State Medicaid Coverage for Tobacco-Dependence Treatments-United States, 1994-2002

MMWR Highlights

January 30, 2004 / Vol. 53 / No. 3


Need for Tobacco-Dependence Treatment Among Medicaid Enrollees

  • Because rates of smoking are highest among people living in poverty, the negative health effects of tobacco use are of major concern for State Medicaid programs.
     

  • Medicaid recipients have approximately 50% greater smoking prevalence than the overall U.S. population.
     

  • In 2000, approximately 11.5 million (36%) adult Medicaid recipients smoked cigarettes.
     

Extent of Coverage for Tobacco-Use Treatments In State Medicaid Programs

  • In 2002, eleven (22%) states offered no coverage for tobacco-dependence treatment under Medicaid, and only New Jersey and Oregon provided coverage for all treatment options recommended by the PHS Clinical Practice Guideline.
     

  • The number of Medicaid programs providing some coverage for counseling or medication increased from 37 (73%) in 2001 to 40 (78%) in 2002.
     

  • In 2002, only 16 (31%) states offered some form of tobacco-dependence counseling services, the primary recommendation for pregnant women.
     

  • Only 11 (28%) state Medicaid programs that provided coverage for tobacco-dependence treatment benefits informed their recipients that these benefits were available to them.
     

  • Of the 40 states that offered any coverage in 2002, all but one covered at least one pharmacotherapy treatment (i.e., Zybanฎ, nicotine nasal spray, nicotine inhaler, nicotine patch, or nicotine gum).
     

  • Data show that co-payments result in decreased use of treatment; however, 20 (57%) states required some form of patient cost sharing, which ranged from $1.00 to $3.00 per prescription.
     

  • According to the Public Health Service (PHS) Clinical Practice Guideline, Treating Tobacco Use and Dependence, treatment with either counseling or medication doubles quit rates.
     

  • The Guide to Community Preventive Services recommends reducing the cost of tobacco-dependence treatments, especially in low-income populations, to increase the use of treatment by smokers attempting to quit and the number of successful quitters.

State Medicaid Coverage for Tobacco-Dependence Treatments-United States, 1994-2002 — Full Report
 


Privacy Policy | Accessibility

TIPS Home | What's New | About Us | Site Map | Contact Us

CDC Home | Search | Health Topics A-Z

This page last reviewed January 29, 2004

United States Department of Health and Human Services
Centers for Disease Control and Prevention
National Center for Chronic Disease Prevention and Health Promotion
Office on Smoking and Health